CATALAYER NEWS
2025 drug approvals: Despite FDA tumult and macro uncertainty, biopharma scored with 55 new products - Fierce Pharma
Source: Fierce Pharma · 2026-01-05
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets